Michael Pearson Returns To Embattled Valeant Pharmaceuticals Amid Cloud Of Uncertainty |
| March 01, 2016 | March 2016 Bond Updates |
|
Michael Pearson is returning to Valeant Pharmaceuticals, the controversial Quebec-based drugmaker that's facing heavy scrutiny into its drug pricing, sales, and accounting practices. |
| View more at: http://www.forbes.com/sites/antoinegara/2016/02/29/michael-pearson-returns-to-embattled-valeant-pharmaceuticals-amid-cloud-of-uncertainty/ |
| Related News |
|